Obesity and other metabolic disorders: an updated evidence-based overview

Editorial note (initial): This article was previously published and has been updated according to scientific and informative criteria to clarify the evidence on obesity and metabolic disorders. The information is for informational purposes only and does not replace individual medical advice.

In brief

• Obesity is a condition of adipose tissue accumulation associated with an increased risk of many chronic diseases and a reduction in life expectancy.
• Epidemiological evidence shows robust associations between excess weight and the risk of type 2 diabetes, cardiovascular diseases, certain cancers, fatty liver disease, and sleep disorders.
• Many observational studies indicate that the risk varies by intensity, duration, and distribution of body fat; causal interpretations require caution.
• For Italy, significant numbers are often cited (e.g., "57,000 deaths annually" in the original document): these should be verified against updated official sources [placeholder: verify source and year].
• Practical recommendations must be individualized: for clinical information, always consult a healthcare professional.

Abstract: what does science say?

Obesity is defined as an excess of fat mass that coincides with metabolic alterations and an increased risk of various chronic diseases. The most solid evidence comes from large observational studies and meta-analyses reporting associations between high body mass index (BMI) and higher overall mortality, as well as an increased risk for type 2 diabetes, cardiovascular diseases, certain types of cancer, and liver diseases. The extent of the risk depends on how high the BMI is, the duration of excess weight, and the distribution of fat (e.g., abdominal accumulation). Imaging studies and some longitudinal studies also suggest an association between excess weight and age-related brain alterations. The available evidence is largely observational: this makes it necessary to distinguish between association and causality and to evaluate possible confounding factors, such as smoking, mobility, and pre-existing health conditions. Finally, exposure modalities (gradualness of overweight, age of onset, comorbidities) influence individual risks. Practical conclusions therefore require caution and clinical contextualization.

Impact on mortality and public health

The body of large epidemiological analyses indicates that high body mass index levels are associated with an increase in all-cause mortality in large and diverse populations. An international study of individual data across hundreds of cohorts has shown consistent associations between overweight/obesity and the risk of premature death across different continents [1]. A comprehensive systematic review confirms a non-linear relationship between BMI and mortality, with risk increasing especially in the more severe obesity classes [2]. These results have important epidemiological value for public health: they show the potential impact of the increasing prevalence of excess weight on healthcare demands and collective morbidity, while noting that absolute numbers vary with population, age, and the presence of other health conditions. For national data (e.g., Italy) and for attributable mortality estimates, it is essential to refer to official and updated reports or burden of disease analyses; where the original document cites "57,000 deaths/year in Italy," we recommend a precise verification of the source and reference year [placeholder: verify source and year].

Main consequences for organs and systems

Excess adipose tissue interacts with organs and systems through metabolic and inflammatory mechanisms that explain many observed associations. Below is a summary by relevant clinical areas.

Metabolic risk: type 2 diabetes and metabolic syndrome

Obesity, and particularly abdominal fat, is a major determinant of insulin resistance: many cohorts show that increased BMI is associated with a marked increase in the risk of developing type 2 diabetes. The relationship is dose-dependent and is observed in large prospective series, confirming that excess weight is an important risk factor at the population level [2]. However, individual risk also depends on genetic factors, diet, physical activity, and other metabolic conditions; therefore, BMI alone does not fully explain the variability of risk.

Cardiovascular diseases

Obesity is associated with hypertension, dyslipidemia, and a higher probability of cardiovascular events. Analyses of large cohorts show that the relationship between BMI and cardiovascular mortality is consistent, although the strength of the association may vary by age and degree of obesity [1][2]. Proposed mechanisms include increased blood pressure, endothelial dysfunction, and chronic inflammatory state related to adipose tissue. Public health policies therefore consider weight control as one of the useful factors for cardiovascular prevention, always in the context of multifactorial interventions.

Cancer risk

Numerous reviews and meta-analyses demonstrate associations between excess weight and the risk of various cancers (e.g., endometrium, colorectal, esophagus, liver, pancreas, kidney), with variations by site and sex. A systematic review of prospective studies has quantified these associations for many tumor sites, supporting the existence of dose-response relationships in some cases [3]. Plausible mechanisms include hormonal alterations, insulin resistance, and chronic inflammation. The association does not imply that obesity is the sole causal factor: it is part of a set of risk determinants.

Liver and non-alcoholic fatty liver disease (NAFLD)

Non-alcoholic fatty liver disease is closely related to overweight and obesity and is growing as a cause of chronic liver disease. Systematic analyses and global reviews show an increase in the prevalence of NAFLD worldwide and a strong association with adiposity indicators and metabolic syndrome [4]. Although progression to cirrhosis is less common, the public health impact is significant given the high prevalence of the condition.

Sleep, breathing, and brain health

Obesity increases the risk of sleep-disordered breathing, particularly obstructive sleep apnea; community studies document increases in prevalence over time that correlate with the greater spread of excess weight [8]. On a neurological level, neuroimaging research has highlighted structural brain differences associated with obesity and overweight, with estimates indicating a higher apparent "brain age" in some samples (a result to be interpreted with caution) [6]. Sleep disorders and metabolic alterations can interact and contribute to an overall worsening of health.

What it means in practice

For the general public, the evidence indicates that excess weight has implications for collective and individual health. This does not mean that BMI alone defines a person's health status: clinical context, personal history, fat distribution, and behavioral factors are all relevant elements. At the population level, reducing environmental risk factors and promoting prevention policies (food environment, accessible physical activity, public health interventions) can decrease the prevalence of obesity and, potentially, its associated disease component. At the individual level, people with overweight or obesity should be referred for a comprehensive clinical evaluation to identify comorbidities (diabetes, hypertension, liver disease, sleep disorders, mental health) and receive personalized advice. Therapeutic choices — including lifestyle modifications, dietary support, and, when indicated, pharmacological or surgical treatments — must be discussed with qualified healthcare professionals; in no case is this text intended to prescribe therapies or replace a medical visit.

Key takeaways

• Obesity increases the risk of many chronic diseases at the population level; the relationship is supported by large observational studies and meta-analyses [1][2][3].
• The severity of the risk varies by BMI, duration of excess weight, and fat distribution (abdominal adiposity is particularly relevant).
• For some conditions (NAFLD, some cancers, diabetes), the link with excess weight is well documented [3][4].
• Related problems include sleep disorders and impact on mental health; bidirectional relationships are possible [5][6][8].
• Interpreting data requires caution: much evidence is observational and subject to confounding; clinical decisions must be personalized.

Limitations of the evidence

Most of the information comes from observational studies: they show associations but do not always allow for the establishment of direct causal relationships. The main limitations include possible confounding (e.g., smoking, socioeconomic status, pre-existing health conditions), imperfect measures of adiposity (BMI does not distinguish lean mass from fat mass or fat distribution), and variation in measurement methods between studies. Some studies include corrections for known factors, but residual confounding may persist. Furthermore, the heterogeneity of the studied populations (age, ethnicity, geographical context) reduces the direct transferability of results to specific groups. Finally, for some outcomes (e.g., progression of NAFLD to cirrhosis, effects of long-term weight loss on mortality), evidence from controlled studies is limited compared to observational evidence; randomized studies and long follow-ups are needed to clarify the sustained impact and benefits of interventions.

Editorial conclusion

Obesity and associated metabolic disorders represent significant public health issues today. The epidemiological evidence accumulated over recent decades consistently shows associations between excess weight and an increased risk of numerous chronic diseases. However, the biological and social complexity of these problems necessitates caution in interpretations: observed associations do not explain all individual variations and cannot always be translated into generic prescriptive messages. For those seeking practical information, the advice is to consult healthcare professionals for a personalized evaluation; at the population level, it remains crucial to combine prevention policies, access to appropriate care, and reduction of inequalities that influence exposure to risk factors.

Editorial note (final)

This article is an updated version of a previously published text. The update was carried out according to criteria of scientific accuracy and informative clarity. The information reported here does not replace the advice of the attending physician. For specific statistical data relating to individual countries or attributable mortality estimates, it is recommended to consult official reports or updated burden of disease analyses [placeholder: verify any national numerical data cited in the original document].

SCIENTIFIC RESEARCH

Below is the list of selected research supporting the statements in the article. Each reference is verified and has a clickable DOI.

1. Di Angelantonio E, Bhupathiraju S, Wormser D, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016. https://doi.org/10.1016/S0140-6736(16)30175-1 [1]
2. Aune D, Sen A, Prasad M, et al. BMI and all-cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies. BMJ. 2016. https://doi.org/10.1136/bmj.i2156 [2]
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008. https://doi.org/10.1016/S0140-6736(08)60269-X [3]
4. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016. https://doi.org/10.1002/hep.28431 [4]
5. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010. https://doi.org/10.1001/archgenpsychiatry.2010.2 [5]
6. Ronan L, Alexander-Bloch A, Wagstyl K, et al. Obesity associated with increased brain age from midlife. Neurobiology of Aging. 2016. https://doi.org/10.1016/j.neurobiolaging.2016.07.010 [6]
7. Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2021. https://doi.org/10.1111/obr.13305 [7]
8. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. American Journal of Epidemiology. 2013. https://doi.org/10.1093/aje/kws342 [8]